Suppr超能文献

人血浆中纤溶酶原激活剂快速作用抑制剂的证明

Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma.

作者信息

Kruithof E K, Tran-Thang C, Ransijn A, Bachmann F

出版信息

Blood. 1984 Oct;64(4):907-13.

PMID:6434006
Abstract

This report describes a plasmatic, fast-acting, specific inhibitor (antiactivator) of tissue-type plasminogen activator (t-PA) and urokinase (UK). After addition of t-PA to human plasma, biexponential decay of activity occurred. The initial rapid inhibition of t-PA activity (half-life of approximately one minute) was correlated with the formation of a complex of a molecular weight of 110,000, suggesting a molecular weight in the order of 40,000 for the antiactivator. Diisopropylfluorophosphate (DFP)-inactivated t-PA did not form complexes with antiactivator. The second-order rate constant for the interaction of t-PA with antiactivator is in the order of 10(7) mol/L-1 sec-1. In plasma, UK added at low concentrations rapidly formed complexes of a mol wt of 95,000. Preincubation of the plasma with t-PA prevented complex formation of UK, and vice versa, suggesting that the same inhibitor inactivates both t-PA and UK. After exhaustion of the antiactivator, t-PA and UK formed complexes with alpha 2-antiplasmin and C1'-inhibitor at a low rate.

摘要

本报告描述了一种血浆中的、快速起效的、组织型纤溶酶原激活剂(t-PA)和尿激酶(UK)的特异性抑制剂(抗激活剂)。将t-PA加入人血浆后,活性呈双指数衰减。t-PA活性的初始快速抑制(半衰期约为1分钟)与形成分子量为110,000的复合物相关,提示抗激活剂的分子量约为40,000。二异丙基氟磷酸酯(DFP)灭活的t-PA不与抗激活剂形成复合物。t-PA与抗激活剂相互作用的二级速率常数约为10(7) mol/L-1 sec-1。在血浆中,低浓度添加的UK迅速形成分子量为95,000的复合物。血浆与t-PA预孵育可阻止UK形成复合物,反之亦然,提示同一抑制剂可使t-PA和UK均失活。抗激活剂耗尽后,t-PA和UK以低速率与α2-抗纤溶酶和C1'-抑制剂形成复合物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验